Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design Collaboration leverages Iktos’ capabilities in machine learning and AI and Zealand expertise in peptide drug discovery PARIS–(BUSINESS WIRE)–Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), … [Read more…]